Search research articles
Contact Us
Filters
Showing results (311-320 of 1,836) with videos related to
Page
of 184
Sort By:
Expert Review of Cardiovascular Therapy
|
September 22, 2009
Spectrum of pericardial disease: part I
Farouk Mookadam, Panupong Jiamsripong, Jae K Oh, et al.
Expert Review of Cardiovascular Therapy
|
September 22, 2009
Spectrum of pericardial disease: part II
Panupong Jiamsripong, Farouk Mookadam, Jae K Oh, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1997
Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A
V Rumsaeng, H Vliagoftis, C K Oh, et al.
The American Surgeon
|
July 1, 1981
Perirenal fluid collection after renal transplant
R Yap, B Madrazo, H K Oh, et al.
Mycopathologia
|
May 1, 1992
Evaluation of antifungal activity of antimycotics by automatic analyzing system
K Oh, H Matsuoka, O Sumita, et al.
Therapeutic Advances in Urology
|
June 3, 2014
The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
Che-Kai Tsao, Elena Cutting, Jacob Martin, et al.
Transplantation
|
January 1, 1988
Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients
W Kupin, K K Venkat, H K Oh, et al.
Hand (New York, N.Y.)
|
June 24, 2017
Effectiveness of Corticosteroid Injections for Treatment of de Quervain's Tenosynovitis
Jinhee K Oh, Susan Messing, Ollivier Hyrien, et al.
Clinical Medicine Insights. Oncology
|
June 23, 2011
Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer
Che-Kai Tsao, Sonia Seng, William K Oh, et al.
European Journal of Immunology
|
October 1, 1987
Biological properties of suppressive E-receptor factor on lymphokine function
S K Oh, M F Leung, T Knee, et al.
Page
of 184
Search research articles
Search
Showing results (311-320 of 1,836) with videos related to
Sort By:
Page
of 184
Expert Review of Cardiovascular Therapy
|
September 22, 2009
Spectrum of pericardial disease: part I
Farouk Mookadam, Panupong Jiamsripong, Jae K Oh, et al.
Expert Review of Cardiovascular Therapy
|
September 22, 2009
Spectrum of pericardial disease: part II
Panupong Jiamsripong, Farouk Mookadam, Jae K Oh, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1997
Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A
V Rumsaeng, H Vliagoftis, C K Oh, et al.
The American Surgeon
|
July 1, 1981
Perirenal fluid collection after renal transplant
R Yap, B Madrazo, H K Oh, et al.
Mycopathologia
|
May 1, 1992
Evaluation of antifungal activity of antimycotics by automatic analyzing system
K Oh, H Matsuoka, O Sumita, et al.
Therapeutic Advances in Urology
|
June 3, 2014
The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
Che-Kai Tsao, Elena Cutting, Jacob Martin, et al.
Transplantation
|
January 1, 1988
Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients
W Kupin, K K Venkat, H K Oh, et al.
Hand (New York, N.Y.)
|
June 24, 2017
Effectiveness of Corticosteroid Injections for Treatment of de Quervain's Tenosynovitis
Jinhee K Oh, Susan Messing, Ollivier Hyrien, et al.
Clinical Medicine Insights. Oncology
|
June 23, 2011
Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer
Che-Kai Tsao, Sonia Seng, William K Oh, et al.
European Journal of Immunology
|
October 1, 1987
Biological properties of suppressive E-receptor factor on lymphokine function
S K Oh, M F Leung, T Knee, et al.
Page
of 184